We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REV
4976
PUT
DELISTED
Revlon, Inc.
REV
$428K ﹤0.01%
+20,000
New +$482K
NXG
4977
NXG NextGen Infrastructure Income Fund
NXG
$346M
$427K ﹤0.01%
7,875
+975
+14% +$51K
PFI icon
4978
Invesco Dorsey Wright Financial Momentum ETF
PFI
$59.2M
$427K ﹤0.01%
11,036
-651
-6% -$24.6K
PHIO icon
4979
Phio Pharmaceuticals
PHIO
$12.5M
$427K ﹤0.01%
8
+3
+60% +$3.45K
AGEN
4980
Agenus
AGEN
$294M
$426K ﹤0.01%
5,341
+2,579
+93% +$173K
IRBT
4981
DELISTED
iRobot
IRBT
$426K ﹤0.01%
8,409
-22
-0.3% -$1.1K
REVG
4982
DELISTED
REV Group
REVG
$426K ﹤0.01%
34,826
+25,905
+290% +$328K
MYOK
4983
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$426K ﹤0.01%
5,841
+5,656
+3,057% +$343K
ALNT icon
4984
Allient
ALNT
$1.95B
$425K ﹤0.01%
13,143
+4,444
+51% +$124K
AMK
4985
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$424K ﹤0.01%
14,603
+5,084
+53% +$133K
TSEM icon
4986
Tower Semiconductor
TSEM
$28.6B
$423K ﹤0.01%
17,597
-399,680
-96% -$8.98M
CGC
4987
CALL
Canopy Growth
CGC
$420M
$422K ﹤0.01%
2,000
-12,750
-86% -$2.53M
NDP
4988
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$421K ﹤0.01%
12,136
-2,426
-17% -$75.9K
FTV.PRA
4989
DELISTED
Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A
FTV.PRA
$421K ﹤0.01%
432
+88
+26% +$81.9K
SYRE icon
4990
Spyre Therapeutics
SYRE
$8.89B
$420K ﹤0.01%
2,200
-147
-6% -$28.9K
HMLP
4991
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$420K ﹤0.01%
26,900
-16,109
-37% -$249K
DVYA icon
4992
iShares Asia/Pacific Dividend ETF
DVYA
$72.1M
$419K ﹤0.01%
9,577
HBCP icon
4993
Home Bancorp
HBCP
$564M
$419K ﹤0.01%
10,673
+3,037
+40% +$118K
INO icon
4994
Inovio Pharmaceuticals
INO
$79.2M
$419K ﹤0.01%
10,565
+4,440
+72% +$134K
USDP
4995
DELISTED
USD PARTNERS LP
USDP
$419K ﹤0.01%
42,291
-16,684
-28% -$165K
SCPL
4996
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$418K ﹤0.01%
+34,039
New +$362K
AEF
4997
abrdn Emerging Markets Equity Income Fund
AEF
$372M
$417K ﹤0.01%
54,752
+2,827
+5% +$20.4K
ALBO
4998
DELISTED
Albireo Pharma Inc
ALBO
$417K ﹤0.01%
16,407
+6,445
+65% +$129K
GIC icon
4999
Global Industrial
GIC
$1.53B
$416K ﹤0.01%
16,522
+5,971
+57% +$139K
HOFT icon
5000
Hooker Furnishings Corp
HOFT
$162M
$416K ﹤0.01%
16,167
+5,265
+48% +$124K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.